Gland Pharma IPO Subscribed 98% So Far On The Final Day
White-colour pills are displayed in this arranged photograph. (Photographer: Brent Lewin/Bloomberg)

Gland Pharma IPO Subscribed 98% So Far On The Final Day

Gland Pharma Ltd.’s initial public offering was nearly fully subscribed on the final day of bidding.The issue was subscribed 98% as of 1:00 pm on Nov. 11, led by institutional investors who bid for...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.